Cargando…

Cell-Specific Type I IFN Signatures in Autoimmunity and Viral Infection: What Makes the Difference?

Gene expression profiling of peripheral blood mononuclear cells (PBMCs) has revealed a crucial role for type I interferon (IFN) in the pathogenesis of systemic lupus erythematosus (SLE). However, it is unclear how particular leucocyte subsets contribute to the overall type I IFN signature of PBMCs a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kyogoku, Chieko, Smiljanovic, Biljana, Grün, Joachim R., Biesen, Robert, Schulte-Wrede, Ursula, Häupl, Thomas, Hiepe, Falk, Alexander, Tobias, Radbruch, Andreas, Grützkau, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877094/
https://www.ncbi.nlm.nih.gov/pubmed/24391825
http://dx.doi.org/10.1371/journal.pone.0083776
_version_ 1782297590682877952
author Kyogoku, Chieko
Smiljanovic, Biljana
Grün, Joachim R.
Biesen, Robert
Schulte-Wrede, Ursula
Häupl, Thomas
Hiepe, Falk
Alexander, Tobias
Radbruch, Andreas
Grützkau, Andreas
author_facet Kyogoku, Chieko
Smiljanovic, Biljana
Grün, Joachim R.
Biesen, Robert
Schulte-Wrede, Ursula
Häupl, Thomas
Hiepe, Falk
Alexander, Tobias
Radbruch, Andreas
Grützkau, Andreas
author_sort Kyogoku, Chieko
collection PubMed
description Gene expression profiling of peripheral blood mononuclear cells (PBMCs) has revealed a crucial role for type I interferon (IFN) in the pathogenesis of systemic lupus erythematosus (SLE). However, it is unclear how particular leucocyte subsets contribute to the overall type I IFN signature of PBMCs and whole blood samples.Furthermore, a detailed analysis describing the differences in the IFN signature in autoimmune diseases from that observed after viral infection has not been performed to date. Therefore, in this study, the transcriptional responses in peripheral T helper cells (CD4(+)) and monocyte subsets (CD16(−) inflammatory and CD16(+) resident monocytes) isolated from patients with SLE, healthy donors (ND) immunised with the yellow fever vaccine YFV-17Dand untreated controls were compared by global gene expression profiling.It was striking that all of the transcripts that were regulated in response to viral exposure were also found to be differentially regulated in SLE, albeit with markedly lower fold-change values. In addition to this common IFN signature, a pathogenic IFN-associated gene signature was detected in the CD4(+) T cells and monocytes from the lupus patients. IL-10, IL-9 and IL-15-mediated JAK/STAT signalling was shown to be involved in the pathological amplification of IFN responses observed in SLE. Type I IFN signatures identified were successfully applied for the monitoring of interferon responses in PBMCs of an independent cohort of SLE patients and virus-infected individuals. Moreover, these cell-type specific gene signatures allowed a correct classification of PBMCs independent from their heterogenic cellular composition. In conclusion, our data show for the first time that monocytes and CD4 cells are sensitive biosensors to monitor type I interferon response signatures in autoimmunity and viral infection and how these transriptional responses are modulated in a cell- and disease-specific manner.
format Online
Article
Text
id pubmed-3877094
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38770942014-01-03 Cell-Specific Type I IFN Signatures in Autoimmunity and Viral Infection: What Makes the Difference? Kyogoku, Chieko Smiljanovic, Biljana Grün, Joachim R. Biesen, Robert Schulte-Wrede, Ursula Häupl, Thomas Hiepe, Falk Alexander, Tobias Radbruch, Andreas Grützkau, Andreas PLoS One Research Article Gene expression profiling of peripheral blood mononuclear cells (PBMCs) has revealed a crucial role for type I interferon (IFN) in the pathogenesis of systemic lupus erythematosus (SLE). However, it is unclear how particular leucocyte subsets contribute to the overall type I IFN signature of PBMCs and whole blood samples.Furthermore, a detailed analysis describing the differences in the IFN signature in autoimmune diseases from that observed after viral infection has not been performed to date. Therefore, in this study, the transcriptional responses in peripheral T helper cells (CD4(+)) and monocyte subsets (CD16(−) inflammatory and CD16(+) resident monocytes) isolated from patients with SLE, healthy donors (ND) immunised with the yellow fever vaccine YFV-17Dand untreated controls were compared by global gene expression profiling.It was striking that all of the transcripts that were regulated in response to viral exposure were also found to be differentially regulated in SLE, albeit with markedly lower fold-change values. In addition to this common IFN signature, a pathogenic IFN-associated gene signature was detected in the CD4(+) T cells and monocytes from the lupus patients. IL-10, IL-9 and IL-15-mediated JAK/STAT signalling was shown to be involved in the pathological amplification of IFN responses observed in SLE. Type I IFN signatures identified were successfully applied for the monitoring of interferon responses in PBMCs of an independent cohort of SLE patients and virus-infected individuals. Moreover, these cell-type specific gene signatures allowed a correct classification of PBMCs independent from their heterogenic cellular composition. In conclusion, our data show for the first time that monocytes and CD4 cells are sensitive biosensors to monitor type I interferon response signatures in autoimmunity and viral infection and how these transriptional responses are modulated in a cell- and disease-specific manner. Public Library of Science 2013-12-31 /pmc/articles/PMC3877094/ /pubmed/24391825 http://dx.doi.org/10.1371/journal.pone.0083776 Text en © 2013 Kyogoku et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Kyogoku, Chieko
Smiljanovic, Biljana
Grün, Joachim R.
Biesen, Robert
Schulte-Wrede, Ursula
Häupl, Thomas
Hiepe, Falk
Alexander, Tobias
Radbruch, Andreas
Grützkau, Andreas
Cell-Specific Type I IFN Signatures in Autoimmunity and Viral Infection: What Makes the Difference?
title Cell-Specific Type I IFN Signatures in Autoimmunity and Viral Infection: What Makes the Difference?
title_full Cell-Specific Type I IFN Signatures in Autoimmunity and Viral Infection: What Makes the Difference?
title_fullStr Cell-Specific Type I IFN Signatures in Autoimmunity and Viral Infection: What Makes the Difference?
title_full_unstemmed Cell-Specific Type I IFN Signatures in Autoimmunity and Viral Infection: What Makes the Difference?
title_short Cell-Specific Type I IFN Signatures in Autoimmunity and Viral Infection: What Makes the Difference?
title_sort cell-specific type i ifn signatures in autoimmunity and viral infection: what makes the difference?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877094/
https://www.ncbi.nlm.nih.gov/pubmed/24391825
http://dx.doi.org/10.1371/journal.pone.0083776
work_keys_str_mv AT kyogokuchieko cellspecifictypeiifnsignaturesinautoimmunityandviralinfectionwhatmakesthedifference
AT smiljanovicbiljana cellspecifictypeiifnsignaturesinautoimmunityandviralinfectionwhatmakesthedifference
AT grunjoachimr cellspecifictypeiifnsignaturesinautoimmunityandviralinfectionwhatmakesthedifference
AT biesenrobert cellspecifictypeiifnsignaturesinautoimmunityandviralinfectionwhatmakesthedifference
AT schultewredeursula cellspecifictypeiifnsignaturesinautoimmunityandviralinfectionwhatmakesthedifference
AT hauplthomas cellspecifictypeiifnsignaturesinautoimmunityandviralinfectionwhatmakesthedifference
AT hiepefalk cellspecifictypeiifnsignaturesinautoimmunityandviralinfectionwhatmakesthedifference
AT alexandertobias cellspecifictypeiifnsignaturesinautoimmunityandviralinfectionwhatmakesthedifference
AT radbruchandreas cellspecifictypeiifnsignaturesinautoimmunityandviralinfectionwhatmakesthedifference
AT grutzkauandreas cellspecifictypeiifnsignaturesinautoimmunityandviralinfectionwhatmakesthedifference